The University of Queensland’s Institute for Molecular Bioscience (IMB) and Life Technologies will collaborate to study pancreatic and ovarian cancer in Australia.
Researchers will use Applied Biosystems’ (part of Life Technologies) SOLiD system for the genomic analysis of pancreatic and ovarian tumors.
Through this collaboration, IMB will acquire nine new SOLiD systems for a total of 11 instruments. IMB is deploying SOLiD sequencing technology for its participation in the International Cancer Genome Consortium (ICGC).